SAUD3 logo

Bradsaúde S.A. Stock Price

BOVESPA:SAUD3 Community·R$40.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author

SAUD3 Share Price Performance

R$13.90
2.48 (21.72%)
R$16.21
Fair Value
R$13.90
2.48 (21.72%)
14.3% undervalued intrinsic discount
R$16.21
Fair Value
Price R$13.90
AnalystConsensusTarget R$16.21
AnalystLowTarget R$11.00
AnalystHighTarget R$18.00

SAUD3 Community Narratives

·
Fair Value R$16.21 14.3% undervalued intrinsic discount

Brazil Dental Insurance Expansion Will Harness Exclusive Bradesco Channel

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
·
Fair Value R$11 26.4% overvalued intrinsic discount

Broader Health Integration And SME Mix Will Pressure Margins And Earnings Quality

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value R$18 22.8% undervalued intrinsic discount

Bank Distribution And Health Ecosystem Integration Will Drive A Stronger Long Term Outlook

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
R$18
22.8% undervalued intrinsic discount
Revenue
7.28% p.a.
Profit Margin
22.46%
Future PE
22.93x
Price in 2029
R$29.64
R$11
26.4% overvalued intrinsic discount
Revenue
4.69% p.a.
Profit Margin
22.97%
Future PE
14.75x
Price in 2029
R$18.11

Trending Discussion

Updated Narratives

SAUD3 logo

SAUD3: Higher Margin Outlook And Index Inclusion Will Drive Repricing

Fair Value: R$16.21 14.3% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SAUD3 logo

Bank Distribution And Health Ecosystem Integration Will Drive A Stronger Long Term Outlook

Fair Value: R$18 22.8% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SAUD3 logo

Broader Health Integration And SME Mix Will Pressure Margins And Earnings Quality

Fair Value: R$11 26.4% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with proven track record.

2 Risks
1 Reward

Bradsaúde S.A. Key Details

R$2.6b

Revenue

R$1.1b

Cost of Revenue

R$1.4b

Gross Profit

R$877.9m

Other Expenses

R$565.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 03, 2026
0.19
56.17%
22.00%
0%
View Full Analysis

About SAUD3

Founded
1987
Employees
1957
CEO
Carlos Alberto Marinelli
WebsiteView website
www.bradescori.com.br/en/bradesco/bradsaude/

Bradsaúde S.A. provides private dental care plans in Brazil. The company operates through Corporate, Small and Medium-Sized Enterprise (SME), Individual, and Other segments. The company manages and sells dental care plans to corporations and/or individuals. It is also involved in commercial advisory, consulting, and business management services; develops and licenses software programs; wholesale and retail trade of products and equipment, sanitizers, drugs, medicines, pharmaceutical inputs, and related items; provision of storage, loading, organization, tidying, custody of goods, technical, and administrative programming services, as well as general management of assets and business. In addition, the company engages in integrating technologies to develop dental solutions; and provide specialized services related to accidents and illnesses, besides actuarial, financial, administrative, and commercial and risk management services. The company was formerly known as Odontoprev S.A. and changed its name to Bradsaúde S.A. in April 2026. Bradsaúde S.A. was founded in 1987 and is headquartered in Barueri, Brazil. Bradsaúde S.A. operates as a subsidiary of Bradesco Saúde S.A.